SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes

por Haupt, T.H., Elfving, B., Eugen-Olsen, J., Mors, O., Köhler-Forsberg, O.
Publicado 2023

Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Stu...

por Rasmussen, Line J. H., Ladelund, Steen, Haupt, Thomas H., Ellekilde, Gertrude E., Eugen-Olsen, Jesper, Andersen, Ove
Publicado 2018

Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population

por Haupt, Thomas H, Kallemose, Thomas, Ladelund, Steen, Rasmussen, Line JH, Thorball, Christian W, Andersen, Ove, Pisinger, Charlotta, Eugen-Olsen, Jesper
Publicado 2014

suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients

por Meyer, Jeppe, Alstrup, Morten, Rasmussen, Line J. H., Schultz, Martin, Ladelund, Steen, Haupt, Thomas H., Tingleff, Jens, Iversen, Kasper, Eugen-Olsen, Jesper
Publicado 2018

Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates

por Fahlberg, M. D., Blair, R. V., Doyle-Meyers, L. A., Midkiff, C. C., Zenere, G., Russell-Lodrigue, K. E., Monjure, C. J., Haupt, E. H., Penney, T. P., Lehmicke, G., Threeton, B. M., Golden, N., Datta, P. K., Roy, C. J., Bohm, R. P., Maness, N. J., Fischer, T., Rappaport, J., Vaccari, M.
Publicado 2020